Iconovo (ICO) - Total Liabilities

Latest as of March 2026: Skr15.48 Million SEK ≈ $1.67 Million USD

Based on the latest financial reports, Iconovo (ICO) has total liabilities worth Skr15.48 Million SEK (≈ $1.67 Million USD) as of March 2026. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities.

Iconovo - Total Liabilities Trend (2015–2025)

This chart illustrates how Iconovo's total liabilities have evolved over time, based on quarterly financial data. See Iconovo short-term liquidity ratio to evaluate short-term liquidity relative to the company's equity base.

Iconovo Competitors by Total Liabilities

The table below lists competitors of Iconovo ranked by their total liabilities.

Company Country Total Liabilities
Sarama Resources Ltd
AU:SRR
Australia AU$1.95 Million
KGW Group Berhad
KLSE:0282
Malaysia RM21.81 Million
Sahathai Terminal Public Company Limited
BK:PORT
Thailand ฿1.74 Billion
DB (International) Stock Brokers Limited
NSE:DBSTOCKBRO
India Rs402.88 Million
exax Inc
KQ:060230
Korea ₩88.82 Billion
The Motor & General Finance Limited
NSE:MOTOGENFIN
India Rs843.31 Million
Rocky Mountain Chocolate Factory
NASDAQ:RMCF
USA $14.72 Million
CMO Public Company Limited
BK:CMO
Thailand ฿719.79 Million

Liability Composition Analysis (2015–2025)

This chart breaks down Iconovo's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the full company profile including market capitalisation, see ICO stock market capitalisation.

Liquidity & Leverage Metrics

Key Metrics Explained

Metric Value Description
Current Ratio 3.70 Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio N/A More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio N/A Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity 0.10 Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets 0.09 Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how Iconovo's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for Iconovo (2015–2025)

The table below shows the annual total liabilities of Iconovo from 2015 to 2025.

Year Total Liabilities Change
2025-12-31 Skr13.16 Million
≈ $1.42 Million
-20.10%
2024-12-31 Skr16.47 Million
≈ $1.77 Million
+13.19%
2023-12-31 Skr14.55 Million
≈ $1.57 Million
-54.48%
2022-12-31 Skr31.97 Million
≈ $3.44 Million
+177.80%
2021-12-31 Skr11.51 Million
≈ $1.24 Million
+38.41%
2020-12-31 Skr8.32 Million
≈ $894.85K
+67.69%
2019-12-31 Skr4.96 Million
≈ $533.64K
-43.11%
2018-12-31 Skr8.72 Million
≈ $937.94K
-17.57%
2017-12-31 Skr10.57 Million
≈ $1.14 Million
-7.06%
2016-12-31 Skr11.38 Million
≈ $1.22 Million
+118.88%
2015-12-31 Skr5.20 Million
≈ $559.38K
--

About Iconovo

ST:ICO Sweden Medical Devices
Market Cap
$12.11 Million
Skr112.52 Million SEK
Market Cap Rank
#26576 Global
#573 in Sweden
Share Price
Skr1.17
Change (1 day)
+0.86%
52-Week Range
Skr1.04 - Skr2.63
All Time High
Skr95.00
About

Iconovo AB (publ) develops inhaled medicinal products in Sweden. The company offers ICOres, a multi-dose dry powder inhaler; ICOcap, a capsule based dry powder inhaler; ICOone, a single-dose disposable dry powder inhaler; and ICOpre, a pre-metered dry powder inhaler; and ICOone nasal single-dose dry powder inhaler for nasal use. It serves generic companies. The company has a collaboration agreeme… Read more